Lanoxin PG 50 micrograms/ml Elixir *
Pharmacy Only: Prescription

  • Company:

    Aspen
  • Status:

    No Recent Update
  • Legal Category:

    Product subject to medical prescription which may be renewed (B)
  • Active Ingredient(s):

    *Additional information is available within the SPC or upon request to the company

Updated on 09 July 2020

File name

Digo_OralSol_IE_S_0.05mg.ml_v5_1594304868.pdf

Reasons for updating

  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 10 - Date of revision of the text

Legal category:Product subject to medical prescription which may be renewed (B)

Updated on 09 July 2020

File name

Digo_OralSol_IE_P_0.05mg-ml_v5_1594304745.pdf

Reasons for updating

  • Change to section 2 - interactions with other medicines, food or drink

Updated on 09 July 2020

File name

Digo_Inj_IE_P_0.25mg-ml_v5_1594304527.pdf

Reasons for updating

  • Change to section 2 - interactions with other medicines, food or drink

Updated on 30 April 2019

File name

Digo_OralSol_IE_S_0.05mg.ml_v4_1556619004.pdf

Reasons for updating

  • New SPC for new product

Legal category:Product subject to medical prescription which may be renewed (B)

Updated on 22 January 2019

File name

Digo_OralSol_IE_P_0.05mg-ml_v4_1548154015.pdf

Reasons for updating

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 2 - excipient warnings
  • Change to section 3 - dose and frequency
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision

Updated on 05 February 2018

File name

PIL_9869_472.pdf

Reasons for updating

  • New PIL for new product

Updated on 05 February 2018

Reasons for updating

  • Change to section 5 - how to store or dispose
  • Change to section 6 - date of revision

Updated on 18 April 2017

Reasons for updating

  • Change to Section 1 - what the product is
  • Change to section 1 - what the product is used for
  • Change to section 2 - what you need to know - contraindications
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - use in children and adolescents
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 2 - pregnancy, breast feeding and fertility
  • Change to section 2 - driving and using machines
  • Change to section 3 - dose and frequency
  • Change to section 3 - use in children/adolescents
  • Change to section 3 - how to take/use
  • Change to section 3 - duration of treatment
  • Change to section 3 - overdose, missed or forgotten doses
  • Change to section 4 - possible side effects
  • Change to section 4 - how to report a side effect
  • Change to section 6 - date of revision

Updated on 08 April 2014

Reasons for updating

  • Change to date of revision
  • Change to MA holder contact details

Updated on 19 November 2013

Reasons for updating

  • Change of active ingredient
  • Change to, or new use for medicine
  • Change to warnings or special precautions for use
  • Change to storage instructions
  • Change to side-effects
  • Change to information about pregnancy or lactation
  • Change to information about driving or using machinery
  • Change to date of revision
  • Change to dosage and administration
  • Addition of information on alternative format leaflets

Updated on 30 January 2013

Reasons for updating

  • Improved electronic presentation

Updated on 27 May 2011

Reasons for updating

  • Change to marketing authorisation holder

Updated on 12 March 2010

Reasons for updating

  • Change to marketing authorisation holder

Updated on 31 January 2006

Reasons for updating

  • Improved electronic presentation

Updated on 26 May 2005

Reasons for updating

  • New PIL for medicines.ie